UK markets closed

Celldex Therapeutics, Inc. (CLDX)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
28.04+0.06 (+0.21%)
As of 12:05PM EDT. Market open.
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2021
31/12/2020
31/12/2019
31/12/2018
Total revenue
823
4,651
7,418
3,573
9,538
Operating expenses
Research development
66,021
53,311
42,534
42,672
66,449
Selling general and administrative
26,128
20,488
14,456
15,426
19,269
Total operating expenses
92,149
73,799
56,990
58,098
85,942
Operating income or loss
-91,326
-69,148
-49,572
-54,525
-76,404
Total other income/expenses net
-8,555
-1,590
-11,375
3,647
-75,545
Income before tax
-99,881
-70,738
-60,947
-50,878
-151,949
Income tax expense
-
-227
-1,167
0
-765
Income from continuing operations
-99,654
-70,511
-59,780
-50,878
-151,184
Net income
-99,654
-70,511
-59,780
-50,878
-151,184
Net income available to common shareholders
-99,654
-70,511
-59,780
-50,878
-151,184
Basic EPS
-
-1.64
-2.02
-3.51
-14.48
Diluted EPS
-
-1.64
-2.02
-3.51
-14.48
Basic average shares
-
42,870
29,640
14,507
10,442
Diluted average shares
-
42,870
29,640
14,507
10,442
EBITDA
-
-66,080
-45,643
-49,667
-72,603